---
archetype: bookmark
categories:
- fda
- medical devices
date: 2019-05-29T09:48:47Z
description: ""
featuredImage: /img/content/post/mobihealthnews-fda-grants-de-novo-clearance-to-smartphone-controlled-acute-migraine-relief-device.JPG
link: https://www.mobihealthnews.com/content/fda-grants-de-novo-clearance-smartphone-controlled-acute-migraine-relief-device
linkBrand: mobihealthnews.com
linkOriginal: https://www.mobihealthnews.com/content/fda-grants-de-novo-clearance-smartphone-controlled-acute-migraine-relief-device
slug: mobihealthnews-fda-grants-de-novo-clearance-to-smartphone-controlled-acute-migraine-relief-device
title: FDA grants De Novo clearance to smartphone-controlled acute migraine-relief
  device
---
Theranica, an Israel-based biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, announced on May 28 that the U.S. Food and Drug Administration (FDA) granted a De Novo request for its smartphone-controlled electroceutical, Nerivio MigraÂ®, utilising Remote Electrical Neuromodulation for the acute treatment of migraine.

